SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-058319
Filing Date
2024-05-08
Accepted
2024-05-07 21:53:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm242764d2_defa14a.htm DEFA14A 13068
2 GRAPHIC tm242764d2_defa14aimg003.jpg GRAPHIC 160466
3 GRAPHIC tm242764d2_defa14aimg004.jpg GRAPHIC 119543
  Complete submission text file 0001104659-24-058319.txt   400091
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 24924027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)